Завантаження...

Bacteriofages delivery by courier and delivery service «Nova Poshta». Place orders by phone 0-800-307-407

Pyofag®

Pyofag®
580
uah / pack

Pyofag®

The product contains bacteriophages specifically eliminating such causative agents of pyoinflammatory and enteric diseases as:

 
  • Streptococcus pyogenes
  • Staphylococcus aureus
  • Escherichia coli
  • Pseudomonas aeruginosa
  • Proteus vulgaris
  • Proteus mirabilis
 

The bacteriophages contained in the product proliferate inside the bacterial cells and destroy them. The bacteriophages also induce activation of immune reactions in the body, preventing recurrence of infectious disease and transition of the inflammatory process into a chronic form.

 

The product does not violate the condition of the normal microflora in the gastrointestinal tract.

 

Pyofag®

The full information on the product is given in the instruction for medical use. Before use read the Instructions for medical use of Pyofag® medicinal product.

 

Indications for use of Pyofag® medicinal product

Drug form

Administration of Pyofag® medicinal product

Dosage

Side effects of Pyofag® medicinal product

Contraindications to administration of Pyofag® medicinal product

Administration of Pyofag® medicinal product during pregnancy and breastfeeding period

Drug-to-drug interaction

Administration details of Pyofag® medicinal product

  • Caution
  • Manufacturer

The information on the product is presented for information purposes only and shall not be used as a guide for self-treatment. Only a doctor can make a decision as to prescribing of the product, as well as doses thereof and method of administration.

News about Pyofag®

Publication about the drug Pyofag®

News Phage preparations in the practice of a general practitioner
01.04.2018

Phage preparations in the practice of a general practitioner

We present to you the presentation "Modern Possibilities of Treatment and Prevention of Microbial Infections in the Practice of a General Practitioner"

News Bacteriophages have been used in the treatment of vascular graft infection
09.03.2018

Bacteriophages have been used in the treatment of vascular graft infection

In the US, a patient with an aortic arch prosthesis infection that was resistant to antibiotics was saved using bacteriophages.

News A symposium on the use of bactriophages in clinical practice will be held in the Netherlands
16.02.2018

A symposium on the use of bactriophages in clinical practice will be held in the Netherlands

To discuss phage therapy issues, a Symposium on the Use of Bactriophages in Clinical Practice will be held in Utrecht, the Netherlands, on February 22, 2018. Leading international experts in the field of phage therapy have been invited to the Symposium.